$BMY News Market rookie Five Prime's shares surge on deal

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
$BMY News

Market rookie Five Prime's shares surge on deal with Bristol-Myers 12:01 p.m. March 17, 2014 - Russ Britt
RadioShack sinks; J.C. Penney gains on S&P outlook hike 5:19 p.m. March 4, 2014 - Sue Chang
Bristol-Myers plans late-stage tests on Yervoy as lung-cancer treatment 5:01 p.m. March 4, 2014 - Russ Britt
Billionaire Stan Druckenmiller's recent moves 12:50 p.m. Feb. 24, 2014 - Insider Monkey
Feds, pharma rivals team up on Alzheimer's 3:32 p.m. Feb. 6, 2014 - Elizabeth O'Brien
Merck hits a new high as analyst sees opening for new cancer drug 12:16 p.m. Jan. 27, 2014 - Russ Britt
U.S. stocks tumble; Dow drops 318 points 6:29 p.m. Jan. 24, 2014 - Anora Mahmudova
Juniper buoyed by Jana stake; Herbalife loss grows 4:50 p.m. Jan. 24, 2014 - Sue Chang
U.S. stock futures trim losses ahead of market open 9:57 a.m. Jan. 24, 2014 - Barbara Kollmeyer
Beam, Honeywell, Procter & Gamble are stocks to watch 6:38 a.m. Jan. 24, 2014 - Sue Chang
AstraZeneca, Bristol-Myers Secure EU OK for Xigduo 3:44 a.m. Jan. 22, 2014 - MarketWatch.com
‘Sloppy’ market turns to consumer, tech earnings 9:01 a.m. Jan. 19, 2014 - Wallace Witkowski
America's best and most generous 401(k)s 3:30 p.m. Jan. 15, 2014 - Anne Tergesen
Merck initiates melanoma filing with FDA 12:45 p.m. Jan. 13, 2014 - Tess Stynes
Statin usefulness questioned, but patent expirations may ease pain 2:02 p.m. Jan. 8, 2014 - Russ Britt
Not all pharmaceuticals are created equal 1:40 p.m. Dec. 26, 2013 - The Trading Deck
FTSE 100 rises, shaking off retail data after Fed taper 1:06 p.m. Dec. 19, 2013 - Sara Sjolin
European stocks rally on Fed taper, rate views 1:00 p.m. Dec. 19, 2013 - Sara Sjolin
AstraZeneca to buy Bristol-Myers diabetes-JV stake 4:25 a.m. Dec. 19, 2013 - MarketWatch.com
Pfizer and Kaiser: They not only rhyme, they're in sync with workers 12:12 p.m. Dec. 10, 2013 - Russ Britt


Tradable Biotech Stocks Events For the Second Quarter 9:00 a.m. Today - TheStreet.com
Why Bristol-Myers Squibb is a Top 25 Dividend Giant (BMY) 5:35 a.m. Today - InvestorPlace.com
China still bright for Big Pharma 11:30 a.m. April 2, 2014 - Seeking Alpha
Glaxo Suffers Another Setback 5:26 a.m. April 2, 2014 - The Wall Street Journal Interactive Edition
3 Stocks Pushing The Drugs Industry Lower 1:03 p.m. April 1, 2014 - TheStreet.com
Sales Soar for Pricey Hepatitis Drug Sovaldi 8:16 p.m. March 31, 2014 - The Wall Street Journal Interactive Edition
Which Pharmas Can Keep Up Dividend-Buybacks? 3:02 p.m. March 31, 2014 - Seeking Alpha
Amgen Stock Gets Bump Up On Cholesterol Drug Data 12:59 p.m. March 31, 2014 - Investors Business Daily
3 Stocks Reiterated As A Buy: MA, SLB, BMY 12:18 p.m. March 31, 2014 - TheStreet.com
Cramer: Keep an Eye on Celgene (CELG), Gilead (GILD), Isis Pharmaceuticals (ISIS) and Seattle Genetics (SGEN) 12:03 p.m. March 31, 2014 - TheStreet.com
Don't Give Up On Momentum 8:36 p.m. March 28, 2014 - Seeking Alpha
Gilead Sovaldi Scrips Falter As Biotechs Keep Falling 3:42 p.m. March 28, 2014 - Investors Business Daily
Government agency plans to shake down Big Pharma 1:54 p.m. March 28, 2014 - Seeking Alpha
A Look Back At Big Pharma Stocks 4:58 p.m. March 27, 2014 - Seeking Alpha
Bristol-Myers Still Lags in Hepatitis C 8:19 a.m. March 27, 2014 - Barrons.com
Jim Cramer's 'Mad Money' Recap: Beware the Vacuum 8:03 p.m. March 26, 2014 - TheStreet.com
3 Stocks Reiterated As A Buy: MSFT, BMY, CAT 12:14 p.m. March 26, 2014 - TheStreet.com
J.P. Morgan Says Buy Specialty and Big Pharmaceuticals Now 8:15 a.m. March 26, 2014 - 247WallSt.com
Novo Nordisk Upgraded to 'Buy' 11:43 a.m. March 24, 2014 - FOXBusiness
Drug Firms Focus on Advanced Melanoma 8:11 p.m. March 23, 2014 - The Wall Street Journal Interactive Edition


Theravance Appoints Kevin Kwok, Head of Talent Acquisition and Strategy 4:05 p.m. April 1, 2014 - Marketwire
Bristol-Myers Squibb to Announce Results for First Quarter 2014 on April 29 9:00 a.m. April 1, 2014 - BusinessWire - BZX
Bristol-Myers Squibb Executive Maclean Becomes Precision Health Economics' Chief Operating Officer 10:22 a.m. March 31, 2014 - PR Newswire - PRF
INNATE PHARMA : Start of cohort expansion of Phase I trial with lirilumab and nivolumab in selected solid tumors 1:50 a.m. March 31, 2014 - GlobeNewswire
In A Subanalysis, The Benefits Of Eliquis® (apixaban) Vs. Warfarin In Reducing The Risk Of Stroke In Patients With Nonvalvular Atrial Fibrillation Were Consistent, Regardless Of Blood Pressure Control 1 8:16 a.m. March 27, 2014 - BusinessWire - BZX
NSCLC Therapeutics in Asia-Pacific Markets to 2019 - Personalized Therapies Focus on Untapped Segment of Squamous Cell Carcinoma to Expand Treatment Pool 4:51 p.m. March 26, 2014 - PR Newswire - PRF
Pharmaceutical Executive to Unveil Brand of the Year Award Recipients at iPharma 2014: CBI's Marketing Innovation Summit 12:11 p.m. March 26, 2014 - PR Newswire - PRF
Five Prime Therapeutics Announces Fourth Quarter and Fiscal 2013 Financial Results 4:30 p.m. March 25, 2014 - GlobeNewswire
Tocagen Names Jamey Skillings, M.D., Chief Medical Officer 8:00 a.m. March 25, 2014 - PR Newswire - PRF
Bristol-Myers Squibb to Present Data for Daclatasvir in Multiple Investigational All-oral Combinations across Hepatitis C Genotypes at The International Liver CongressTM 5:39 a.m. March 24, 2014 - BusinessWire - BZX
FDA Approvals, Financial Highlights, Restated Treatment Indications, and Updates on Product Pipelines - Analyst Notes on Bristol-Myers Squibb, Galena, Teleflex, GW Pharmaceuticals, and CytRx 8:00 a.m. March 21, 2014 - PR Newswire - PRF
Trace One Names Mark Martini as Vice President of North America to Lead Sales and Customer Development 9:01 a.m. March 20, 2014 - BusinessWire - BZX
Portola Pharmaceuticals Initiates Phase 3 Study of Andexanet Alfa, Potential First-in-Class Factor Xa Inhibitor Reversal Agent, Under Accelerated Approval Pathway 8:15 a.m. March 19, 2014 - GlobeNewswire
Health Care Stocks Review -- Research on Bristol-Myers Squibb, Johnson & Johnson, Merck & Co. and Eli Lilly 8:00 a.m. March 19, 2014 - PR Newswire - PRF
Five Prime Therapeutics and Bristol-Myers Squibb Sign Collaboration Agreement to Discover Novel Immuno-Oncology Therapies for Two Immune Checkpoint Pathways 6:59 a.m. March 17, 2014 - BusinessWire - BZX
Five Prime Therapeutics and Bristol-Myers Squibb Sign Collaboration Agreement to Discover Novel Immuno-Oncology Therapies for Two Immune Checkpoint Pathways 6:59 a.m. March 17, 2014 - GlobeNewswire
U.S. FDA Approves Eliquis® (apixaban) To Reduce The Risk Of Blood Clots Following Hip Or Knee Replacement Surgery 1:00 p.m. March 14, 2014 - BusinessWire - BZX
Investment Grants, Data Presentations, Clinical Study Results, and Collaborative Programs - Analyst Notes on UnitedHealth Group, Bristol-Myers Squibb, AbbVie, Cigna, and OXiGENE 8:00 a.m. March 14, 2014 - PR Newswire - PRF
Pharma-Biotech Industry Helps Drive $14.4 Billion Industrial Project Activity in Massachusetts, an Industrial Info News Alert 6:30 a.m. March 10, 2014 - Marketwire
Medivir: SVR12 Results from a Phase IIa Study Evaluating Simeprevir and Daclatasvir in Hepatitis C Patients of Genotype 1 Have Been Presented 12:30 p.m. March 4, 2014 - BusinessWire - BZX

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Med Spa Visits: Key Insights from Lindsey Smith

Updated Category News Views 4

Moving Beyond the Fear Factor Stepping into a med spa for the first time can be nerve-wracking, especially if you're unsure of what to expect. Lindsey Smith, an expert from Flawless Med Spa in Bryant, Arkansas, knows just how critical it is to navigate this terrain with clarity. Her approach emphasizes building a foundation of trust and understanding from the get-go. Fear...

Continue Reading
Insta360 Expands with Times Square Flagship Store

Updated Category News Views 7

Insta360 Times Square Opening Marks Bold Expansion I dropped by Times Square today, and what do I see? Insta360 planting its flag right in the heart of New York City. Now, this isn't your run-of-the-mill grand opening—it’s the first flagship store outside of Asia, and it screams of big ambitions. Nestled at 1515 Broadway, the store is smack in the middle of one of the...

Continue Reading
Why Liver Nurture Taps into Health Sector Trends

Updated Category News Views 5

Liver Wellness: A Sector on the Rise Remember when everyone was all about heart health and cholesterol levels? Seems like these days, folks have shifted their focus a bit south—right to the liver. It's no surprise, really. With our modern diet and lifestyle choices squeezing the life out of this hard-working organ, people are on the hunt for ways to give it the TLC it...

Continue Reading
Qatar Foundation Spurs Sport-Driven Empowerment Moves

Updated Category News Views 4

Here we go, diving into the serious talk of the moment: sports pushing boundaries to uplift society's underdogs. Envision yourself in the halls of Wilton Park, where the thinkers, the dreamers, and the doers convened in the name of change. Qatar Foundation ain't just sitting pretty; they're championing the cause to harness sport for impactful social threads across the...

Continue Reading
BarrelPick.com Launches for Bourbon Aficionados

Updated Category News Views 4

Just when you think you've seen all the ways to enjoy bourbon, along comes BarrelPick.com with a tantalizing new proposition. They're throwing down the gauntlet for bourbon lovers everywhere by letting you buy an entire barrel, let it sit around for a bit, watch it mature, and then call the shots on when it finally sees the light of day in a bottle. Talk about skipping...

Continue Reading
Papa John's Faces Class Action Over Misleading Info

Updated Category News Views 5

Trouble Brewing for Papa John's Investors Rolling the dice in the stock market sometimes feels like playing the lottery, doesn't it? This time around, it's Papa John's (NASDAQ: PZZA) serving up a slice of turmoil for its investors. The pizza chain's got itself tangled in a class-action lawsuit, and it's the shareholders who're left with a bitter taste. Investors Cry Foul...

Continue Reading
Flying Car Regulatory Sandbox Begins in UAE

Updated Category News Views 9

Pioneering Flying Cars in the Desert In a move that seems right out of a science fiction screenplay, ARIDGE—the bigwig of flying cars from Asia—has taken a giant leap. They’ve cozied up with the UAE, locking arms to cook up the world's first regulatory sandbox for personal flying cars. Now, don’t laugh—sandbox isn't just for toddlers. It’s the playground where...

Continue Reading
Tragedy Highlights Need for E-bike Safety Overhaul

Updated Category News Views 6

A Dire Wake-Up Call in the East Village We're staring hard at a heartbreaking mess in the East Village. A 15-year-old girl lost her life while riding an electric Citi Bike, hit by an industrial truck. Let's not dance around it—this is a gut punch, the kind you never want to ever hear about, and one that comes with a bitter flavor of 'what if?' Age Verification: A...

Continue Reading
USPS Rolls Out Christmas Cookie Stamps Nationwide

Updated Category News Views 5

USPS Delivers Nostalgia with Cookie-Themed Stamps Let's talk stamps, folks. The U.S. Postal Service has rolled out its newest Christmas Cookies Forever stamps, bringing a dash of sugary nostalgia to mailboxes nationwide. The release was celebrated at the Smithsonian National Postal Museum, spotlighting a tradition as sweet as the sugar cookies themselves. These aren't...

Continue Reading

Top 5 Most Recently Viewed Articles

Starwood Property Trust Sets Conference Call for 2024 Results

Updated Category News Views 131

Starwood Property Trust Sets Conference Call for 2024 Results Starwood Property Trust (NYSE: STWD) recently announced an important date for investors. The company is gearing up to release its financial results for the fourth quarter and full year of 2024. This release is scheduled for an upcoming Thursday, shortly before the trading day begins on the New York Stock...

Continue Reading
Daryl Allen Joins Pivot Bio as New Sales Vice President

Updated Category News Views 346

Pivot Bio Welcomes Daryl Allen as Vice President of Sales Pivot Bio, recognized as a pioneering force in agricultural technology, has announced the significant appointment of Daryl Allen as vice president of sales. With over thirty years in the ag-tech industry, Allen will be stepping into his new role, reporting directly to Chris Turner, the chief commercial officer....

Continue Reading
Kymera Therapeutics Secures $602 Million in Public Offering

Updated Category News Views 244

Kymera Therapeutics Secures $602 Million in Public Offering Kymera Therapeutics, Inc. (NASDAQ: KYMR), a leader in the clinical-stage biopharmaceutical sector, has recently announced a significant milestone in its financial journey by pricing an upsized public offering totaling $602 million. This pivotal offering embodies Kymera's commitment to advancing innovative...

Continue Reading
ROPET Redefines Companionship with Innovative AI Robot

Updated Category News Views 545

ROPET Redefines Companionship with Innovative AI Robot ROPET, a pioneering robotics company focused on enhancing human connections through technology, recently showcased its latest creation at CES 2025: an AI-powered robot companion. This advanced robot pet goes beyond typical smart devices by offering a unique blend of warmth and emotional intelligence, setting a new...

Continue Reading
Exploring Sterling Infrastructure's Impressive Stock Growth Over 15 Years

Updated Category News Views 263

Growth of Sterling Infrastructure Stock Over the Years Sterling Infrastructure (NASDAQ: STRL) has shown impressive financial performance over the past 15 years, significantly outpacing market averages by an impressive 13.0% annually. This remarkable growth translates to an average annual return of 25.16%, showcasing the company's ability to generate wealth for its...

Continue Reading